SCHEMBL16416700

SCHEMBL16416700

CCc1cnc(NC(=O)Nc2cc(C)ccc2OCC2CCCNC2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 9/20 0.49
▸ FECH P22830 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.42
▸ SCN9A Q15858 1/20 0.39
▸ PLK4 O00444 1/20 0.39
▸ PDPK1 O15530 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ CSF1R P07333 1/20 0.39
▸ RET P07949 1/20 0.39
▸ FER P16591 1/20 0.39
▸ FLT4 P35916 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ CLK2 P49760 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ IRAK1 P51617 1/20 0.39
▸ RPS6KA3 P51812 1/20 0.39
▸ STK3 Q13188 1/20 0.39
▸ BRSK1 Q8TDC3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2033685 0.91 CHEK1 (0.53) CHEK1FECHKCNH2KDM4ESCN9A
SCHEMBL13997115 0.86 CHEK1 (0.48) CHEK1FECHKCNH2KDM4ESCN9A
Hydrochloric Acid SCHEMBL5059305 0.86 CHEK1 (0.47) CHEK1FECHKCNH2KDM4ESCN9A
SCHEMBL6892368 0.82 CHEK1 (0.47) CHEK1FECHKCNH2KDM4E
SCHEMBL5163065 0.80 CHEK1 (0.49) CHEK1FECHKCNH2SCN9A
SCHEMBL5163178 0.80 CHEK1 (0.49) CHEK1FECHKCNH2SCN9A
SCHEMBL5163078 0.80 CHEK1 (0.49) CHEK1FECHKCNH2SCN9A
SCHEMBL2036465 0.78 KDM4E (0.66) CHEK1KDM4E
SCHEMBL13997114 0.77 IDH2 (0.47) CHEK1FECHKCNH2SCN9A
Hydrochloric Acid SCHEMBL5063346 0.76 IDH2 (0.47) CHEK1FECHKCNH2SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3024456-A1 COMBINATORIAL METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE Update Pharma Inc. (US) 2016-06-01 — — EP disclosed
EP-3024457-A1 COMPOSITIONS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE Update Pharma Inc. (US) 2016-06-01 — — EP disclosed
WO-2015013579-A1 COMPOSITIONS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE UPDATE PHARMA INC. (US) 2015-01-29 — — WO disclosed
WO-2015013581-A1 COMBINATORIAL METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE UPDATE PHARMA INC. (US) 2015-01-29 — — WO disclosed
Send feedback